Sempra Outlook - Mixed Signals Amid Volatile Technicals and Strong Fund Flows

Market Snapshot

Stable but cautious: Sempra (SRE) is currently trading in technical neutrality, with recent signals showing a volatile market and no clear directional bias.

News Highlights

Recent news impacting Sempra includes:

• Stryker leads West Michigan’s largest publicly traded companies: Stryker’s 10.2% revenue growth highlights strong performance in health care, contrasting with manufacturing sector declines.
• SouthState Corporation files SEC Form S-3ASR: This move may signal capital-raising efforts or restructuring plans.
• Independent Bank director plans to sell $3.5M in shares: The proposed sale might temporarily influence market sentiment due to insider activity.

Analyst Views & Fundamentals

The simple average analyst rating for Sempra is 3.00, while the performance-weighted rating is 3.33. Analyst ratings show some dispersion, with Barclays recently giving a "Neutral" rating.

These ratings are broadly in line with the current price trend (up 0.65%), suggesting that market expectations are relatively neutral. However, fundamental performance has shown mixed results:

• Basic Earnings Per Share (YoY growth rate): -12.13% – internal diagnostic score: 4.09
• Diluted Earnings Per Share (YoY growth rate): -12.18% – internal diagnostic score: 4.81
• Total Profit (YoY growth rate): -7.08% – internal diagnostic score: 0.73
• Net Profit Attributable to Parent Company Shareholders (YoY growth rate): -9.71% – internal diagnostic score: 3.69
• Net Assets Per Share (Growth Rate): 1.31% – internal diagnostic score: 1.08

Notably, both basic and diluted earnings are showing significant declines, which could concern long-term investors.

Money-Flow Trends

Big-money activity appears bearish. The overall inflow ratio is 49.33%, with all major categories (Large, Extra-large, and Block) trending negatively. This suggests that institutional investors are currently cautious.

Internal diagnostic score for fund flow: 7.81 (good), indicating that despite the bearish trend, there's still strong volume participation across all levels of fund flows.

Key Technical Signals

Technically, the outlook remains mixed. The technical score is 5.0 (technical neutrality, mainly wait-and-see). Here are the key indicators:

• Bullish Engulfing – internal diagnostic score: 7.59
• WR Oversold – internal diagnostic score: 6.75
• WR Overbought – internal diagnostic score: 3.50
• MACD Golden Cross – internal diagnostic score: 2.97
• Marubozu White – internal diagnostic score: 4.17

Key recent indicators by date include:

• 2025-09-12: WR Overbought, Three White Soldiers, MACD Golden Cross
• 2025-09-11: WR Overbought
• 2025-08-29: Bullish Engulfing
• 2025-09-09: Marubozu White
• 2025-09-08: WR Oversold

Technical indicators suggest a volatile market with no clear direction, emphasizing the importance of monitoring short-term price changes.

Conclusion

Investors should consider waiting for a clearer trend to emerge. While the fundamentals and fund flows show some strength, the technical signals remain mixed. A pullback or stronger bullish confirmation could make Sempra a more compelling buy. For now, watch for volatility and avoid overcommitting without additional clarity.